Oral Steroid Safely Treats IgA Nephropathy: Trial Published Oral Steroid Safely Treats IgA Nephropathy: Trial Published

Delayed-release budesonide reduced proteinuria in patients with primary IgA nephropathy in a pivotal trial, which led to an FDA accelerated approval in December 2021 for the orphan drug.Medscape Medical News
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Nephrology News Source Type: news